Management of Anxiety in Patients with Seizure Disorders

Medication Considerations

The American Academy of Child and Adolescent Psychiatry recommends close monitoring for increased seizure activity when using escitalopram, especially during the first months of treatment, following dosage adjustments, and when combined with other medications that may lower seizure threshold 1
The American Academy of Child and Adolescent Psychiatry suggests starting with lower doses and titrating slowly to minimize the risk of seizure exacerbation when using escitalopram 1
The Annals of Emergency Medicine recommends ensuring antiepileptic medications are optimized before starting escitalopram, and monitoring for drug interactions with antiepileptic medications 2, 3
The American Academy of Child and Adolescent Psychiatry advises against combining multiple serotonergic agents in patients with seizure disorders as this increases risk 1
The Annals of Emergency Medicine suggests considering EEG monitoring if clinically indicated, especially with escitalopram 3
Praxis Medical Insights recommends considering benzodiazepines, particularly lorazepam, for short-term use in severe anxiety symptoms due to their anticonvulsant properties 4

Tricyclic antidepressants (TCAs) carry a higher seizure risk (0.4-2%) and should generally be avoided, with amitriptyline having documented seizure risk and cardiac complications 5
TCAs increase cardiac arrest risk (OR 1.69) 5
Maprotiline has a high seizure risk 5
Benzodiazepines, particularly lorazepam, have no reported QT prolongation in clinical use and can be used short-term due to their anticonvulsant properties 5, 6
Valproate, carbamazepine, and lamotrigine are mood stabilizers with anticonvulsant properties that can be considered for dual benefit 5, 6

Begin duloxetine at 30 mg once daily for the first week, then increase to the standard 60 mg once daily to reduce adverse effects in adults with a seizure disorder who are otherwise stable on anticonvulsant therapy. This recommendation is based on a 2010 Mayo Clinic Proceedings article and reflects moderate‑level clinical evidence. 7